Professor, Neurology, University Kansas School of Medicine
Mazen M. Dimachkie, MD, FAAN, FANA, is Professor of Neurology, Director of the Clinical Neurophysiology Division and Director of the Neuromuscular Section, at the University of Kansas Medical Center (KUMC) in Kansas City, where he is also Director of the Clinical Neurophysiology Fellowship and Neuromuscular Medicine Fellowship programs. As the director of KUMC Neuromuscular Research, he manages one of the busiest neuromuscular clinical trials units in North America. He is also Associate Director of the Heartland Unit for Neuroscience Trials as part of the KUMC participation in the NINDS Network for Excellence in Neuroscience Clinical Trials known as NeuroNEXT. He received his medical degree from the American University of Beirut in Lebanon before completing an internship in Internal Medicine at Saint Agnes Hospital in Baltimore, Maryland. Dr. Dimachkie then completed a residency in Neurology and a fellowship in Neuromuscular Disease at The University of Texas Health Science Center at Houston. He is board-certified in Neurology, Clinical Neurophysiology and Neuromuscular Medicine.
Dr. Dimachkie is a member of the American Neurological Association (Fellow member), American Academy of Neurology (Fellow member), American Association of Neuromuscular & Electrodiagnostic Medicine, the Peripheral Nerve Society and The Neuropathy Association. He was elected as fellow member of the American Academy of Neurology and of the American Neurological Association. He is a frequently invited lecturer in the fields of neuromuscular neurology, and he has authored or co-authored more than 200 abstracts, articles, and book chapters. He is involved in a wide variety of federally-funded neuromuscular research studies as well industry-sponsored studies, nationally and internationally. Dr. Dimachkie’s neuromuscular research interests are broad and include amyotrophic lateral sclerosis, neuropathies, myasthenia gravis and myopathies.
Phase II Trial of Rituximab In Myasthenia Gravis Start of enrollment: 2014 May 01 Mohammad Alsharabati, MD, David P Richman, MD, Perry B Shieh, MD, PhD, Dianna Quan, MD, Richard J Nowak, MD, MS, Michael Benatar, MD, Mazen Dimachkie, MD, Volkan Granit, MD, Joanathan M. Goldstein, MD, Em...
International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01 David Saperstein, Shafeeq Ladha, Michael Graves, Richard Nowak, Michael Pulley, Senda Ajroud-Driss, James Gilchrist, Robert M. Pascuzzi, Mazen Dimachkie, Mazen Dimachkie, MD, Justin Kwan, MD, Tony Amato, ...
The full profile is locked and available to verified physicians only. Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile
Physicians, view Dr. Dimachkie's full Doximity profile to: